The benefit to be derived from mammographic examinations is conditioned by subjects' compliance with regular examinations, and this compliance depends partly on psychological aspects of the experience and the subject's perception of the examination. A mammography can indeed be unpleasant, whether physically or psychologically, and it is important to alleviate and minimise this. The MammoGraphy Questionnaire (MGQ) developed and validated in Norway, explores perceptions of mammography and specifically addresses interactions with radiology health professionals, the organisation of the examination, and the physical environment in which it occurs. The aim of this article is to present the adaptation into French of this questionnaire. A translation/adaptation procedure involving five translators whose native language was French or English, four clinicians and one language professional, was conducted. This procedure focused on producing conceptual equivalence between the source instrument (the published English translation of the MGQ) and the final French version, integrating patient experience in the context of a mammography, and choosing wordings of an accessible and acceptable language register for subjects from the target population.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1684/bdc.2008.0578 | DOI Listing |
PLoS One
January 2025
SingHealth Polyclinics, Singapore, Singapore.
Background: Breast cancer is the most common cancer in women, and mammogram screening can reduce breast cancer mortality. Healthcare providers' perspectives can have an impact on encouraging females to attend mammogram screening.
Objective: To understand healthcare providers' (HCPs) perspectives in initiating discussion on mammogram screening, and their perceived barriers and enablers to screening in women.
PLoS One
January 2025
Department of Public Health, The Research Unit for General Practice and Section of General Practice, University of Copenhagen, Copenhagen, Denmark.
Background: Many medical organisations recommend continuing with existing mammography screening programmes but some recommend stopping or de-intensifying them. In Denmark women aged 50-69 are offered biennial mammograms free-of-charge.
Objectives: The aim of this study was to determine whether or not an informed public would recommend continuation of the Danish mammography screening programme, and to determine whether this recommendation was in line with what participants considered to be acceptable levels of mortality reduction and overdiagnosis.
Introduction: Incorporation of mammographic density to breast cancer risk models could improve risk stratification to tailor screening and prevention strategies according to risk. Robust evaluation of the value of adding mammographic density to models with comprehensive information on questionnaire-based risk factors and polygenic risk score is needed to determine its effectiveness in improving risk stratification of such models.
Methods: We used the Individualized Coherent Absolute Risk Estimator (iCARE) tool for risk model building and validation to incorporate density to a previously validated literature-based model with questionnaire-based risk factors and a 313-variant polygenic risk score (PRS).
BMC Womens Health
January 2025
Department of General Surgery, İstanbul Faculty of Medicine, İstanbul University, İstanbul, 34093, Türkiye.
Background: The Bahçeşehir population-based mammography screening program (BMSP) is an example of Türkiye's first population-based screening program. This study aims to reveal the successful implementation of population-based secreening program in one of the low- and middle-income countries, Türkiye and long-term results of patients diagnosed with breast cancer during BMSP.
Methods: This study was conducted between 2009 and 2019, in the Bahçeşehir county of Istanbul.
JAMA Netw Open
January 2025
Medical Oncology, The Ottawa Hospital Cancer Centre, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.
Importance: Evolving breast cancer treatments have led to improved outcomes but carry a substantial financial burden. The association of treatment costs with the cost-effectiveness of screening mammography is unknown.
Objective: To determine the cost-effectiveness of population-based breast cancer screening in the context of current treatment standards.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!